Results 181 to 190 of about 38,036 (248)
Neurovascular effects of tadalafil in patients with cerebral small vessel disease: ETLAS-2 substudy. [PDF]
Ölmestig J +9 more
europepmc +1 more source
Balancing lung and brain: physiological strategies for ARDS management in acute brain injury. [PDF]
Robba C +12 more
europepmc +1 more source
ABSTRACT Background Heated, humidified, high‐flow nasal cannula (HFNC) before intubation has been associated with increased mortality in children with immunocompromising conditions (ICC). Objectives We sought to describe HFNC failure (intubation) rate and aimed to develop a novel score associated with HFNC failure.
Michelle A. Mai +2 more
wiley +1 more source
Inflammatory Prognostic Markers in COPD: Clinical Utility of CAR and MGPS. [PDF]
Düger M, Tomas G, Başlılar Ş.
europepmc +1 more source
In this case series of 18 patients with amyotrophic lateral sclerosis and intolerance to non‐invasive ventilation, high‐flow nasal cannula was feasible as home‐based respiratory support. Gas exchange remained stable during follow‐up despite progressive functional decline, supporting further evaluation of HFNC as an alternative or complementary strategy
Fabio Varon‐Vega +5 more
wiley +1 more source
Early Postnatal Hypocapnia and Hypercapnia in Ventilated Preterm Infants: Incidence and Associations with Adverse Outcomes. [PDF]
Chatziioannidis I +7 more
europepmc +1 more source
This case demonstrates that medium‐flow ECCO2R can serve as an effective bridge to therapy in AECOPD combined with central airway stricture, safely correcting refractory hypercapnia and providing a stable window for successful bronchoscopic stenting and ventilator weaning. ABSTRACT This case report highlights a novel and successful therapeutic strategy
Jingjing Deng +3 more
wiley +1 more source
Hypercapnia dissociates neuronal and hemodynamic responses impairing neurovascular coupling and functional brain connectivity. [PDF]
Gezginer I +4 more
europepmc +1 more source
Update on the Pathophysiology, Aetiology and Management of Central Sleep Apnoea
ABSTRACT Central sleep apnoea (CSA) of the periodic breathing type occurs during the transition between wakefulness and stage 1 and 2 non‐REM sleep. In adults at sea level, it occurs most commonly due to advanced heart failure (HF) or chronic opioid use and in ~5% of obstructive sleep apnoea patients initiating CPAP.
Sahan D. Chandrasekara +1 more
wiley +1 more source
Effect of epileptogenesis on hypercapnic cardioventilatory response in kainic acid rats. [PDF]
Apaire A +7 more
europepmc +1 more source

